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Glycoside hydrolase families 33 and 34 catalyse the hydrolysis of terminal sialic acid residues from sialyl oligosaccharides and
glycoconjugates with a net retention of the stereochemistry at the anomeric centre. It is generally believed that the conserved
aspartic acid in the active site functions as a general acid to protonate the hydroxyl group of the departing aglycone during
glycosylation, and then as a general base to facilitate the nucleophilic attack of the water molecule on the intermediate state
during the deglycosylation reaction. The dual role of the general acid/base places specific demands upon its protonation state, and
thus pKa values. However, it is not fully understood how this catalytic residue can achieve such pKa cycling during catalysis. We
present both MM and combined QM/MM simulations to characterise the pKa values of the proposed catalytic general acid/base
in the glycoside hydrolase families 33 and 34. Collectively, our study suggests that the binding of anionic substrates and the
local solvation properties along with the neutralisation of the nearby glutamic acid upon glycosylation modulate the electrostatic
environment around the general acid/base to achieve its proper protonation states.
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Introduction

Glycoside hydrolases (GHs, or glycosidases) catalyse the hydrolysis of carbohydrates and play a variety of key roles in biological processes. They have many practical applications in
medicine and biotechnology [1]. GH can be categorised into
two distinct mechanistic classes: retaining and inverting GHs,
depending on the stereochemistry of the hydrolysis product
with respect to that of the reactant [2–6]. The insightful 1953
paper by Koshland hypothesized the molecular mechanisms
for both retaining and inverting GHs [7]. Inverting GHs operate via a direct displacement of the leaving group by water
employing a pair of carboxylic acids at the active site with
one serving as the general acid and the other one serving as
the general base. In contrast, retaining GHs catalyse hydrolysis via a double-displacement mechanism. In the first step,
a general acid catalyst (almost always Asp or Glu) facilitates
the departure of the leaving group. A second residue acts as
nucleophile (most commonly a carboxylate residue) to stabilise an enzyme sequestered intermediate state. The second
step of the reaction would be the near microscopic reverse of
the first step; the general base facilitates the attack by a lytic
water on the anomeric centre to break down the intermediate state, forming the product with retained stereochemistry at
a
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the anomeric centre. With typical rate enhancements of up to
1017 -fold, GHs are among the most proficient enzymes; thus,
understanding the structural, dynamic, and electrostatic bases
underlying the mechanisms remains the subject of considerable scientific effort.
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Fig. 1 The proposed catalytic mechanism for GH33 and 34.

Sialic acid is the common name for O- and N-substituted
derivatives of a nine carbon monosaccharide called neuraminic acid [8]. These acids lie on the terminal position of
cell surface glycoproteins and glycolipids and play an important role in molecular recognition by the immune system [9].
GH33 and 34 catalyse the hydrolysis of sialosides with a net
retention of the stereochemistry at the anomeric centre. It has
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been shown that both families use a tyrosine/glutamate couple as the catalytic nucleophile, rather than the more common
single glutamate found in the majority of the retaining GHs
(Figure 1). It has been rationalised that this is most likely due
to the chemical nature of the substrate, sialic acid, which possesses a carboxylate group adjacent to the anomeric centre.
This would introduce unfavourable electrostatic interactions
between the negatively charged nucleophile and the carboxylate group. By employing a tyrosine/glutamate nucleophilic
pair, the tyrosine residue, deprotonated by the nearby glutamate residue, is able to perform nucleophilic attack without facing such repulsive electrostatic interactions (Figure 1).
This mechanism is supported by the recent captured covalent
intermediate state for both Trypanosoma cruzi trans-sialidase
(TcTS, GH33) and influenza neuraminidase (NA subtype N9,
GH34) using either an enzyme mutant or a substrate that
exhibits slow turnover [10–12]. Trypanosoma cruzi transsialidase is a key enzyme associated with infection by Trypanosoma cruzi, which causes the tropical parasitic disease,
Chagas disease. TcTS catalyses the transfer of sialic acids
from mammalian host cells to parasitic cell surfaces in order
to escape detection by the immune system. It has been proposed as a promising target for the development of therapeutics to treat Chagas disease [13]. Influenza neuraminidase is a
proven anti-influenza drug target. Zanamivir and oseltamivir,
among the four licensed prescription influenza antiviral agents
available, target NA [14]. Considering their great medical relevance, both enzymes have been subjected to extensive experimental studies [15, 16]. Complementary combined quantum mechanics/molecular mechanics (QM/MM) simulations
demonstrated that the substrate binding significantly shifted
the pKa value of the nucleophile Tyr342 in TcTS - enabling
the proton transfer from the hydroxyl group of a tyrosine to
a carboxylate group [17]. QM/MM free energy studies of the
catalytic mechanism of TcTS confirm the experimental findings that the reaction processes through a long-lived covalent
intermediate state [18].
It is generally believed that the conserved Asp59 in TcTS or
Asp151 in NA functions as both a general acid and a general
base during the catalysis in the double-displacement mechanism (Figure 1). Such a dual catalytic role, accompanying the
so-called “pKa cycling”, requires that the enzymes are able to
control its protonation state at each step of the catalysis: from
the apo-state, to the Michaelis complex state, to the intermediate state. pKa cyclings are well-precedented for acid/basecatalysed hydrolysis of glycoside [19–21]. Numerous studies
have focused on dissecting the molecular factors that establish the pKa values of the catalytic residues in retaining GHs
including hen gee white lysozyme [22, 23] and Bacillus circulans xylanase [19, 21]. It has been postulated that pKa cycling
is likely to be a common phenomenon in retaining GHs. A
full understanding of the structural and energetic basis for pKa
2|
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cycling is thus essential for a complete description of their catalytic mechanisms. It has been noted that in the apo structures
Asp59 in TcTS (PDB code: 1MS3 [24]) or Asp151 in NA
(PDB code: 2QWA [25]) might not function as an acid catalyst
since it is largely solvent exposed and hence it may have a pKa
too low to allow it to serve such a role under physiologicallyrelevant pHs. On the other hand, based on the the Michaelis
complex obtained for TcTS (PDB code: 1S0I [26]), one might
argue that the position of the aromatic side chain of Tyr119
and the binding of the aglycone of the substrate will significantly decrease the solvent exposure of Asp59. Furthermore,
the anionic nature of the substrate itself (the carboxyl group in
sialosides) might raise the pKa of Asp59 even further.
A key question prompted is what molecular features in
GH33 and 34 establish the pKa values of the general acid/base
in the free, Michaelis complex and glycosyl-enzyme form.
Complementary to experimental studies, combined QM/MM
simulations has been proven to be a powerful alternative in revealing mechanistic insights. In computational enzymology,
a major challenge is to develop computational algorithms to
accurately describe the highly heterogeneous electrostatic environment within these macromolecules, and to delineate the
factors modulating the precise pKa values of ionisable groups
in enzymes, as required to identify the catalytically competent protonation state and understand the catalytic mechanisms
[27]. Their protonation states are determined by the intrinsic pKa of the functional groups and the microenvironment
created by the enzyme structure, which often perturbs their
intrinsic pKa s to their so-called functional or apparent pKa s.
Such pKa shifts can be achieved by interactions between the
catalytic group with other charged or polar groups, or by the
polarity or dielectric of the medium that surrounds it [28].
From a computational point of view, it is very challenging
for methods purely relying on continuum electrostatics or empirical models to capture the variation in pKa s involving substantial structural and energetic changes in a heterogeneous
system. Microscopic simulations based on MM or QM/MM
with explicit solvent representations, therefore, are preferred
in these challenging cases where the explicit solvation and
structural reorganisation need to be properly taken into account. Such simulations bring additional insights into the
mechanistic modulation of the pKa s for catalytically important residues.
In the current work, we apply different computational methods to calculate the pKa shifts of the general acid/base Asp59
in TcTS of GH33 and Asp151 in NA of GH34. There are
two main goals for this study. First, we hope to reconcile the
proposed roles for Asp59 in TcTS and Asp151 in NA with
their protonation states at different catalytic steps. Second,
we would like to explore the microscopic origins for such pKa
shifts in these two enzymes, and more broadly, in the families
of GH33 and 34.

2
2.1

Computational details
Structure preparation and classical MD simulations

All the simulations were carried out using the program
CHARMM (version c38a1) [29]. The protein and substrate
atoms are described with the all-atom CHARMM force field
c36 [30] and the water molecules are described with the TIP3P
model [31]. The efficient General Solvent Boundary Potential
(GSBP) setup [32] was adopted to simulate a spherical region
of 20 Å radius centred on the carboxyl group of interest with
explicit water molecules. Water molecules are added to the
system following the standard protocol of superimposing the
system with a water sphere. In all cases, the system is partitioned into a 20 Å inner region, while the rest of the protein is
treated as the outer region within the GSBP framework. The
long-range interactions were taken into account in the form of
the solvent-shielded static field and the solvent-induced reaction field via 196 harmonic functions in the multipole expansion. The solvent-shielded static field and the reaction-field
matrix were calculated once with finite-difference PoissonBoltzmann (PB) equation, assuming a dielectric constant of
1.0 inside the protein, immersed in a solvent with a dielectric constant of 78.5. The atomic Born radii for protein atoms
used to set up the dielectric boundaries in the PB calculations
were optimised by free energy perturbation/molecular dynamics (FEP/MD) simulations with explicit solvent models [33].
Non-bonded interactions within the inner sphere are treated
with an extended electrostatics model, in which charge groups
beyond 12 Å interact as multipoles. The water molecules
within the inner region were confined by a non-polar cavity
potential to prevent entry into the surrounding dielectric continuum. Newton’s equations of motion are solved for the MD
region (within 18 Å), and Langevin equations of motion are
solved for the buffer region (18-20 Å) with a temperature bath
of 298.15 K. All the bonds involving hydrogen atoms are kept
rigid with the SHAKE algorithm [34] and the time-step is set
to 1.0 fs.
As starting structures for the simulations, we used the X-ray
structures of TcTS (PDB code: 1MS3 [24], resolution 1.65 Å
and 1S0I [26], resolution 1.60 Å) and NA (subtype N9, PDB
code: 2QWB [25], resolution 2.00 Å and 3W09 [12], resolution 2.00 Å). In the case of the structures solved for an inactive mutant, the residue was mutated back to the wild-type
sequence. All the simulated systems are summarised in ESI
Table 1.
2.2

Combined QM/MM MD simulations

An efficient and approximate density function theory
(DFTB3) [35] was adopted as the QM method in the combined
QM/MM simulations [36–41]. DFTB3 is a recent extension
of the self-consistent-charge density-functional tight-binding

method (SCC-DFTB) [42, 43] and derived from a third order
expansion of the density functional theory total energy around
a given reference density [35]. It has been shown to substantially improve the description of charged systems, especially
regarding hydrogen binding energies and proton affinities. As
a result, DFTB3 is particularly applicable to biomolecular systems. As shown by benchmark calculations on proton affinities using G3B3 as reference (for details, see ESI Table 4),
DFTB3 is appropriate for the current system of interest. The
QM/MM boundary (between the Cα and Cβ in Asp or the
Cβ and Cγ in Glu and Tyr) is treated using link-atoms with
the divided frontier charge scheme (DIV as implemented in
CHARMM) [44]. The starting structures for the QM/MM
simulations are taken from the equilibrated MM simulations.
The setup details are identical to the MM simulations. Unless explicitly stated, the QM region includes the side chain of
Asp59 in TcTS or Asp151 in NA (ESI Table 1).
ΔG(E-Asp(H/D))

E-AspH

AspH

ΔG(model-Asp(H/D))

E-AspD

AspD

Fig. 2 The thermodynamics cycle used to calculate the pKa shifts
for the general acid/base in GH33 and 34 with explicit solvent
simulations. The upper leg represents the free energy difference
when perturbing the proton (H) into a dummy atom (D) for the
aspartic acid in a protein (E). The lower leg represents the free
energy difference when perturbing the proton (H) into a dummy
atom (D) for an isolated aspartic acid with neutral blocking groups
in aqueous solution. The double free energy difference between the
two legs is defined as
∆∆G = ∆G(E-Asp(H/D)) − ∆G(model-Asp(H/D)).

2.3

pKa calculations

The thermodynamics cycle used to calculate pKa shifts, i.e.
the pKa difference between an aspartic acid side chain in a
protein and the same group in solution (aspartate), is shown in
Figure 2 [45, 46]. The pKa shifts are then calculated according
to Equation 1.
∆pKa

= pKa (E-Asp) − pKa (model-Asp)
1
=
∆∆G
2.303kT

(1)

The apparent pKa (pKa (E-Asp)) can be calculated based on
the experimental data for pKa (model-Asp) of 3.8.
The pKa calculations were first carried out with either the
continuum electrostatics based method (PB) or an empirical
function based method (PROPKA) [47]. The PB calculations
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were carried out for the X-ray structures with the PBEQ module within CHARMM [29]. The calculations were performed
in two steps, first using a coarse grid spacing of 1.50 Å followed by a focusing around the main region with a finer grid
spacing of 0.25 Å centred at the ionisable group of interest.
The atomic Born radii optimised by explicit solvent FEP/MD
simulations were adopted [33]. The free energy differences
(∆G(E-Asp(H/D)) and ∆G(model-Asp(H/D))) were obtained
by solving the PB equations both in the gas phase (with the dielectric constant set to 1.0) and in the aqueous solution (with
the dielectric constant of water set to 78.5). The dielectric constant of protein was to set to either 4.0 or 8.0 and the salt concentration was set to 0.150 M. In contrast, PROPKA adopts
a very fast empirical energy function that takes into account
the desolvation effects and intra-protein interactions and the
most recent version has also been shown to provide a reliable
treatment for the coupling between the protein and its ligands,
which is crucial for the current study[47].
For explicit solvent representation, the pKa calculations
were carried with both MM and combined DFTB3/MM simulations using a thermodynamic integration approach within
the Dual Topology Single Coordinate scheme [45]. Such simulations have been used in several different systems and have
been shown to successfully reproduce the experimental pKa
shifts of small molecules in solutions and (semi)-buried ionisable residues in proteins [48–51]. The free energy differences
(∆G(E-Asp(H/D)) and ∆G(model-Asp(H/D))) are determined
by integrating the converged free energy derivatives (δ G/δ λ )
over the coupling parameter λ from 0 (the protonated state)
to 1 (the deprotonated state). Specifically, 11 evenly spaced
windows between 0 and 1 were adopted in the current simulations. To carefully monitor the statistical and sampling errors
and reproducibility of the microscopic pKa simulations, multiple independent trajectories have been carried out by starting
the FEP simulations from different structures collected from
equilibrium MM and QM/MM simulations (See ESI Table 5
and 6 for more details). As a reference, ∆G(model-Asp(H/D))
is estimated to be -47.3 kcal/mol with the MM simulation and
121.2 kcal/mol with the DFTB3/MM simulation, respectively.

3

diate state (3W09-int), despite numerical differences between
different methods (PB vs. PROPKA) and different structures used (1MS3 vs. 1S0I). For the Michaelis complex, the
PB calculations predicted that Asp59 in TcTS will be protonated (1S0I-holo) while Asp151 in NA remains deprotonated
(2QWB-holo). PROPKA predicted that both remain deprotonated in the Michaelis complex (1S0I-holo and 2QWB-holo),
which is not consistent with their proposed role as a general
acid in the first step of hydrolysis. Systematic pKa predictions with PROPKA on all the available structures for GH33
and 34 families failed to capture the proposed pKa upshifts
upon ligand binding (ESI Table 2 and 3). The discrepancy
is most likely due to the uncertainties in the pKa calculations
using PBEQ or PROPKA when dealing with residues where
protonation or deprotonation is accompanied with substantial
change in their local solvation environment (e.g. from largely
solvent exposed to deeply buried), as it is seen in other cases
[50].
Table 1 The pKa values of Asp59 in TcTS or Asp151 in NA based
on the Poisson-Boltzmann equation (PBEQ) or the empirical
method PROPKA.
PBEQa
PROPKA
εp = 4 εp = 8
Asp59 in Trypanosoma cruzi trans-sialidase
1MS3-apo
3.4
3.3
2.2
1S0I-apo
4.2
3.9
2.1
1S0I-holob
9.6
7.4
2.4
1S0I-holo2c
8.3
6.7
3.1
Asp151 in influenza neuraminidase
2QWB-apo
4.1
4.1
3.6
2QWB-holob
5.1
4.9
3.6
3W09-int
4.4
4.3
4.2
Structure

Deprot.
Deprot.
Deprot.

A reference pKa value of 3.8 for Asp in aqueous solution was applied. b
The complexed ligand is lactose sialic acid; c The complexed ligand is sialic
acid. d The predicted protonation states from the PBEQ and PROPKA calculations. If they are consistent with each other, a protonation state is assigned;
Additionally if they are consistent with their proposed role in Figure 1, it is
shown in bold otherwise in italic. If the two methods are not consistent with
each other, it is noted by a ?.

Results and Discussions
pKa calculations based on the Poisson-Boltzmann
equation and PROPKA

The pKa values of the proposed general acid Asp59 in TcTS
and Asp151 in NA were predicted based on either the PoissonBoltzmann equation implemented in the PBEQ module in
CHARMM [29] or the empirical method PROPKA 3.1 [47]
(Table 1). These calculations consistently indicate that Asp59
in TcTS and Asp151 in NA should be deprotonated in the apo
state (1MS3-apo, 1S0I-apo and 2QWB-apo) and the interme4|

Deprot.
Deprot.
?
?

a

3.2
3.1

Protonationd
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pKa calculations based on explicit solvent simulations

To overcome the known limitations of pKa calculations based
on the continuum electrostatics protocol or the empirical
method, we carried out additional pKa shift calculations of
Asp59 in TcTS and Asp151 in NA with explicit solvent
simulations, using both the classical MM potential and the
combined QM/MM potential (Table 2). The final snapshots
from these equilibrium DFTB3/MM simulations are shown
in Figure 3 and the heavy-atom root-mean-square deviations
(RMSD) from the X-ray structure for the active site residues

(a)

(b)

Arg314

Arg314
Tyr342

Tyr342
Glu230

Arg35

Glu230

Arg35

Asp59

Arg53
Arg53

Asp59
Arg93
Arg93

(c)

(d)

(e)

Tyr406

Tyr406

Arg371
Glu277

Arg118

Arg371

Tyr406

Glu277

Glu277

Arg371
Arg118

Asp151

Arg118
Asp151

Arg156

Arg156
Arg152

Arg152
Arg156
Asp151

Arg152

Fig. 3 The final snapshots at 20 ns from the DFTB3/MM simulations. The catalytic Asp59, Glu230 and Tyr342 in TcTS and Asp151, Glu277,
Tyr406 in NA are shown explicitly together the substrate and the key nearby residues. The aliphatic hydrogen atoms are omitted for clarity.
The water molecules within 4.0 Å of OD2 in Asp59 or Asp151 are shown in red. (a) 1S0I-apo; (b) 1S0I-holo; (c) 2QWB-apo; (d)
2QWB-holo; (e) 3W09-int.

and the substrate are about 0.8–1.2 Å. Three different snapshots from these equilibrium simulations (20 ns, 30 ns and 40
ns in MM and 10 ns, 15 ns and 20 ns in DFTB3/MM) were
taken as the initial structures for explicit solvent FEP simulations. Encouragingly, both MM and QM/MM simulations
offer a consistent picture of the protonation states of Asp59
in TcTS and Asp151 in NA. In the apo state, Asp59 in TcTS
(1MS3-apo and 1S0I-apo) and Asp151 in NA (2QWB-apo)
are deprotonated. For Asp59 in TcTS, two different structures were used as the starting conformations in the equilibrium MD simulations (1MS3 and 1S0I) for the apo state. Both
setups predicted that Asp59 in TcTS in the apo state has a
pKa well below 7 (on average 3.2 and 1.7 for MM, 0.8 and
1.0 for QM/MM) and this indicates that the results are not
very sensitive to the exact structure adopted in the simulations. When the substrate binds, they have a substantial pKa
upshift, and become protonated (1S0I-holo and 2QWB-holo,
Table 2), consistent with their proposed role as a general acid
in the first step (Figure 1). It is worth noting that there is a
semi-quantitative agreement between the MM and QM/MM
simulations. The advantage of using a QM/MM rather than a
MM potential here is largely due to the convenience of com-

putational setup and our general interest in understanding enzymatic reactions with combined QM/MM methods; the ability to reproduce pKa shifts serves as a stringent benchmark
for QM/MM simulations - especially those involved in proton
transfers. For the case of the glycosyl-enzyme intermediate
state in NA (3W09-int), only QM/MM simulations were carried out since there is no published CHARMM force field parameters available for the glycosyl-enzyme covalent linkage.
The pKa calculations predict that the pKa of Asp151 in NA
is about 6.3. It is 2.4 pKa units lower than the 2QWB-holo
state. This pKa shift is smaller than that between the 2QWBapo state and 2QWB-holo state (4.6 pKa units with QM/MM),
which is expected since the possible structural and energetic
perturbations accompanying the formation of the intermediate
state is smaller than those induced by the binding of an anionic
substrate.
The predicted pKa s from the explicit solvent simulations
are consistent with available experimental data. It has been
shown that TcTS has an apparent optimal pH of 7.9 [52], under which in the Michaelis complex state (1S0I-holo) Asp59
will be protonated to serve as the general acid (pKa : 9.6 with
MM and 8.5 with QM/MM, Table 2). The predicted optimal
1–10 | 5

pH range for NA is between 6.3 and 8.7 from QM/MM pKa
calculations, imposed by the required protonation states of the
general acid/base Asp151 during the catalysis cycle (Table 2).
This is in quite a good agreement with the experimental estimation. NA has a broad pH curve and the optimal pH has
been measured to be around 6.0 (e.g. 5.9 for H4N2 [53], 6.4
for H3N2 [54] and 6.5 for H1N1 [55]).
3.3

Perturbative analysis of the general acid/base pKa

To gain additional insights into the importance of a particular
molecular factor modulating the pKa s of the general acid/base
in GH33 and 34, we carried out a set of perturbative analyses,
in which the energy gap between the protonated state and the
deprotonated state is reevaluated for the snapshots from the
thermodynamic integration of the QM/MM trajectories, after
some of the parameters in the QM/MM coupling model are
modified. For instance, the effect from the desolvation effects
is evaluated by setting the partial charges on the TIP3P water
model to zero, and re-calculating the free energy derivatives
(by calculating the new energy gap) in the original trajectories
for the different λ windows. Strictly speaking, the effects of
individual factors are not additive [56] and the relaxation of
the modified environment after such perturbation is neglected.
Thus, such a perturbative analysis should be treated only qualitatively. Previous studies suggest that even though such a perturbative analysis tends to overestimate the absolute magnitude of contributions, especially those from charged residues,
the relative trends are meaningful. It can provide valuable information about how the environment influences the pKa of
the general acid/base. The results from the perturbative analyses are summarised in Table 3.
As a reference, consider the deprotonation of NH3 -AspOCH3 in solution, the contribution from the surrounding water
is about -41.9 kcal/mol. When setting the partial charges on
all the water molecules to zero, the net contribution from water in 1S0I-apo and 2QWB-apo are relatively small, about -1.3
kcal/mol and -7.4 kcal/mol. The reorganisation of the water
upon deprotonation (which is related with the variation of the
water contribution as a function of λ ) however, is substantial;
in other words water molecules respond significantly to the
change in the protonation state of Asp (See ESI Table 7). Interestingly, the water contributions in 1S0I-holo and 2QWB-holo
are systematically larger than those in 1S0I-apo and 2WQBapo. The net contributions are about -47.3 kcal/mol and -41.9
kcal/mol respectively. These aspects of the water contribution are expected, considering that the overall change in charge
upon deprotonation is the same between the apo state and the
holo state, however, the overall charge of the systems are different for the apo state and the holo state due to the negative
charge on the substrate (-1.0 e). The contributions from water
can also be rationalised from the solvation structure of Asp59
6|
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in TcTS or Asp151 in NA. Water distribution around the carboxylic oxygen in Asp59 or Asp151 from DFTB3/MM are
shown in Figure 4. For 1S0I-apo and 2QWB-apo, there are
about 6-7 water molecules within the first solvation shell of
Asp59 or Asp151 at both λ = 0.0 and λ = 1.0 (with a cutoff
of 4.0 Å). This is consistent with the observation that in the
apo state Asp59 or Asp151 are largely solvent exposed and
the coordination numbers for the protonated and deprotonated
isolated Asp in aqueous solution are 7.4 and 8.0, respectively.
With the binding of the substrate, the coordination numbers
decrease to 1.6 (λ = 0.0) and 3.6 (λ = 1.0) in 1S0I-holo and 4.6
(λ = 0.0) and 6.3 (λ = 1.0) in 2QWB-holo. From this, we can
conclude that the substrate binding makes Asp59 or Asp151
less exposed to water and contributes to their observed pKa
upshifts. The same trend is observed in the case of 2QWBholo when comparing with 2QWB-apo.
In all four cases, the protein atoms make a major contribution, on the order of more than -80 kcal/mol (Table 3). In contrast, the protein reorganisation during deprotonation, which
is reflected by the variation of the protein contribution to the
free energy as a function of λ , is substantially smaller than
water (ESI Table 7). This suggests that the groups making
larger contributions to the deprotonation process have limited
flexibility, which is reflected in their very similar equilibrated
structures (Figure 3). Strikingly, the perturbative contributions
from different residues are almost identical between the apo
state and the holo state (Figure 5), the exception being residue
R118 and R119 in 2QWB which is likely due to the small
structural differences between the apo and holo state (Figure
3 c and d). In other words, the difference in the pKa values
between the apo state and the holo state is most likely not due
to the protein. As expected from the chemical nature of the
substrate, its binding contributes significantly to the pKa shifts
of Asp59 and Asp151, being 48.4 kcal/mol and 40.2 kcal/mol
for 1S0I and 2QWB respectively (Table 3). This is largely
compensated by the tightly coupled protein and water contributions resulting in a net pKa upshift of 7.5 and 4.6 for Asp59
and Asp151 with QM/MM simulations, respectively. Taken
together the perturbative analysis, we demonstrate that the
binding of substrates upshifts the pKa of Asp59 and Asp151
through both reducing the solvent exposure and the increased
electrostatic repulsion.
From the holo state (2QWB-holo) to the covalent intermediate state (3W09-int), a pKa downshift of 2.4 (from 8.7 to
6.3 with QM/MM) was observed (Table 2). In the glycosylenzyme intermediate state, the solvent exposure for Asp151 is
similar to those in 2QWB-holo (Figure 4 b, d) and this suggests that the change in the solvation structure might not be
the dominant factor. The inclusion of Glu277, Tyr406 and the
substrate with DFTB3 in the 3W09-int simulations prevents a
comparative perturbative analysis as in Table 3. The contribution from the individual remaining MM protein residues from

Table 2 The pKa values of Asp59 in TcTS or Asp151 in NA based explicit solvent simulationsa .
Simulations

MM
A
B
C
Ave.c
Asp59 in Trypanosoma cruzi trans-sialidase
1MS3-apo
3.4
3.6
2.7 3.2±0.5
1S0I-apo
1.1
2.2
1.8 1.7±0.6
1S0I-holo
9.8 10.2 8.9 9.6±0.7
Asp151 in influenza neuraminidase
2QWB-apo
5.3
5.6
6.0 5.6±0.4
2QWB-holo 8.4
9.0
9.6 9.0±0.6
3W09-int
-

Protonationb

A

DFTB3/MM
B
C
Ave.

1.1
0.5
7.8

0.4
1.0
8.4

0.9
1.4
9.2

0.8±0.4
1.0±0.5
8.5±0.7

Deprot.
Deprot.
Prot.

4.2
8.8
6.6

4.0
8.3
6.4

4.2
9.0
5.9

4.1±0.1
8.7±0.4
6.3±0.4

Deprot.
Prot.
Deprot.

c

a

A reference pKa value of 3.8 for Asp in aqueous solution was applied; ∆G(Asp) is estimated to be -47.3 kcal/mol with MM and 121.2 kcal/mol with
DFTB3/MM; b See Table 1 footnote d for more details; c The average pKa s from three different sets of simulations. The error bars in pKa calculations are
estimated from the standard deviation of the three sets of calculated values.

the perturbation analysis gives a very similar profile to those
from 2QWB-apo and 2QWB-holo, except Glu277 which is
treated with QM in the 3W09-int simulations (Figure 5). Another important factor in modulating the pKa of the general
acid/base in retaining GHs is the interaction between the two
carboxylic acids in the nucleophile and the general acid/base
[27]. In this scenario from the holo state (2QWB-holo) to
the covalent intermediate state (3W09-int), it is the neutralisation of Glu277 upon glycosylation, eliminating the negative
charge thus changing the electrostatic interactions between
Glu277 and Asp151 (Figure 1). The perturbative analysis
in the 2WQB-holo simulation shows that protonating Glu277
will decrease the deprotonation free energy for Asp151 by
14.4 kcal/mol (i.e. decrease the pKa by 10.5 pKa units) due to
the decreased electrostatic repulsion. This is consistent with
the experimental data on Bacillus circulans xylanase. The
pKa for the corresponding general acid/base Glu172 decreases
from 6.7 in the apo state and the Michaelis complex state to
4.2 in the covalent intermediate state (i.e. 2.5 pKa units) [19].
Mutagenesis study also showed that mutating Glu78 to a neutral glutamine causes the pKa of Glu172 in the apo state to decrease from 6.7 to 4.2 (2.5 pKa units) [19]. All this evidence
indicates that charge neutralisation, either by glycosylation or
mutagenesis, results in a decrease in the pKa of the general
acid/base, facilitating a thermodynamically favourable deprotonation, thus making Asp151 serve as a general base in the
second step.

4

Conclusions

For glycoside hydrolase families 33 and 34, based on the highresolution crystal structure, an Asp in the active site within
hydrogen bonding distance of the glycosidic oxygen has been
proposed as the acid catalyst for the initial glycosyl-enzyme
formation and the same aspartic acid acts as the general base
catalyst for nucleophilic attack in the following deglycosyla-

Table 3 Perturbation analysis of the deprotonation free energy of
Asp59 or Asp151 with DFTB3/MM simulationsa .
System
Ref.b
∆Allc
∆Wate
∆Prote
NH3 -Asp-OCH3 in water
Asp
121.4
163.3
Asp59 in Trypanosoma cruzi trans-sialidase
1S0I-apo
117.2
202.2
118.5
199.4
1S0I-holo
127.3
203.3
174.7
220.1
Asp151 in influenza neuraminidase
2QWB-apo
121.5
201.4
114.1
211.5
2QWB-holo
127.0
199.6
168.9
213.5

∆Lig f
78.9
86.8

a

The deprotonation free energy of Asp59 in TcTS or Asp151 in NA were
calculated by integrating the free energy derivatives recalculated from the
DFTB3/MM FEP trajectories under different QM/MM coupling perturbations. The values are in kcal/mol; b Ref. refers to the perturbative analysis on
the originally simulated systems while keeping all the parameters untouched;
c All the partial charges on the protein (inter and outer atoms), water and the
substrate were set to zero; e All the partial charges on water were set to zero; e
All the partial charges on the protein (inter and outer atoms) were set to zero;
f All the partial charges on the substrate were set to zero.

tion step. It is intriguing how this aspartic acid is capable of
such pKa cycling, particularly serving as a general acid within
a high solvent exposed environment where its pKa is too low.
The current study, utilising the microscopic free energy perturbation with both MM and QM/MM models, demonstrates
that in GH33 and 34 at least two molecular factors are at play:
the binding of the substrate significantly decreases its solvent
exposure, and the electrostatic nature of the anionic substrate
itself further substantially raises the pKa as a consequence of
the repulsive electrostatic interactions. The striking difference
between GH33 and 34 and other retaining GHs, including
lysozyme [22, 23] and xylanase [19, 21], is the characteristic anionic nature of the substrate (sialosides). Upon binding,
the negative charge on the substrate, within the close proximity to the general acid/base, provides much stronger per1–10 | 7
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Fig. 4 Water distribution around the carboxylic oxygen in Asp59 in
TcTS or Asp151 in NA from the DFTB3/MM simulations. (a)
Radial distribution function of water oxygens around the carboxylic
oxygen atom in Asp59 in the simulations of 1S0I; (b) Radial
distribution function of water oxygens around the carboxylic oxygen
atom in Asp151 in the simulations of 2QWB and 3W09; (c) The
coordination number for water around the carboxylic oxygen atom
in Asp59 in the simulations of 1S0I; (d) The coordination number
for water around the carboxylic oxygen atom in Asp151 in the
simulations of 2QWB and 3W09.

turbation to its pKa s. In the following deglycosylation step,
the neutralisation of the nearby nucleophile (glutamic acid)
introduces a downshift in the pKa of this catalytic residue and
thus it becomes deprotonated to serve as a general base. Altogether, our studies suggest that the electrostatic perturbation
upon substrate binding and glycosylation, coupled with the
change in the local solvation environment, serve to precisely
establish the required pKa s for its dual role during the hydrolysis. This study offers a complementary atomistic view of the
pKa cycling in GH33 and 34 and also provides a basis for future studies on glycoside hydrolyases and transferases, where
there are substantial debates over their catalytic mechanisms.
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Fig. 5 Contribution to the electrostatic component of the free
energy of deprotonation from protein atoms (only MM atoms are
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